(MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…
Source link : https://www.medpagetoday.com/dermatology/psoriasis/116153
Author :
Publish date : 2025-06-18 20:22:00
Copyright for syndicated content belongs to the linked Source.
